Literature DB >> 25131717

Risky behavior and correlates of HIV and Hepatitis C Virus infection among people who inject drugs in three cities in Afghanistan.

Horacio Ruiseñor-Escudero1, Andrea L Wirtz2, Mark Berry3, Iliassou Mfochive-Njindan4, Feda Paikan5, Hussain A Yousufi5, Rajpal S Yadav6, Gilbert Burnham4, Alexander Vu7.   

Abstract

BACKGROUND: Injecting drug use is the primary mode of HIV transmission and acquisition in Afghanistan. People who inject drugs (PWID) in the country have been characterized by high risk injecting behavior and a high burden of HCV infection. We aimed to estimate the burden of HIV, HCV, and other infectious diseases and to identify the correlates of HIV and HCV infection among PWID living in three major Afghan cities in 2009.
METHODS: Epidemiologic data was collected among PWID for the integrated biological and behavioral surveillance (IBBS) survey between May and August, 2009 in three Afghan cities. Data were collected using a structured questionnaire and biologic specimens to screen for HIV, HBV, HCV, syphilis, and HSV-2 using rapid testing kits. Multiple logistic regression models were constructed to identify correlates of infection.
RESULTS: Among 548 participants, pooled HIV prevalence was 7.1% (Mazar-i-Sharif: 1.0%, Kabul: 3.1%, Herat: 18.4%) and HCV prevalence was 40.3%. Almost all participants with HIV infection were co-infected with HCV (94.9%). Pooled prevalence estimates for other diseases included 7.1% for HBV, 5.5% for syphilis; and 9.3% for HSV-2. Living in Herat, ever in prison and time injecting were independently associated with HIV infection. Living in Kabul, Herat and time injecting were independently associated with HCV infection.
CONCLUSIONS: There is a high and heterogeneous burden of HIV and HCV among PWID in Afghan cities. Provision of comprehensive harm reduction services to PWID in Afghanistan is warranted to reduce exposures associated with HIV and HCV infection, especially in the city of Herat.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Afghanistan; HBV; HCV; HIV; HSV; PWID

Mesh:

Year:  2014        PMID: 25131717     DOI: 10.1016/j.drugalcdep.2014.07.022

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  7 in total

Review 1.  Early initiation of antiretroviral treatment: Challenges in the Middle East and North Africa.

Authors:  Sara Sardashti; Mehrnoosh Samaei; Mona Mohammadi Firouzeh; Seyed Ali Mirshahvalad; Fatemeh Golsoorat Pahlaviani; SeyedAhmad SeyedAlinaghi
Journal:  World J Virol       Date:  2015-05-12

Review 2.  Determinants of health among people who use illicit drugs in the conflict-affected countries of Afghanistan, Colombia and Myanmar: a systematic review of epidemiological evidence.

Authors:  Sally O'Brien; Margarita Marin Jaramillo; Bayard Roberts; Lucy Platt
Journal:  Confl Health       Date:  2022-07-07       Impact factor: 4.554

3.  Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdul Nasir; Mohammad Raza Stanekzai; Katja Fiekert; Heather L Sipsma; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2015-10-16

Review 4.  Understanding injecting drug use in Afghanistan: A scoping review.

Authors:  Frishta Nafeh; Sufiat Fusigboye; Bundit Sornpaisarn
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-09-19

Review 5.  Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.

Authors:  Shah Jahan Shayan; Rajab Nazari; Frank Kiwanuka
Journal:  Harm Reduct J       Date:  2021-05-27

Review 6.  The global and regional prevalence of hepatitis C and B co-infections among prisoners living with HIV: a systematic review and meta-analysis.

Authors:  Hasan Ahmadi Gharaei; Mohammad Fararouei; Ali Mirzazadeh; Golnaz Sharifnia; Marzieh Rohani-Rasaf; Dariush Bastam; Jamileh Rahimi; Mostafa Kouhestani; Shahab Rezaian; Mostafa Dianatinasab
Journal:  Infect Dis Poverty       Date:  2021-07-01       Impact factor: 4.520

7.  A public health approach to hepatitis C control in low- and middle-income countries.

Authors:  Amitabh B Suthar; Anthony D Harries
Journal:  PLoS Med       Date:  2015-03-10       Impact factor: 11.069

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.